Olaparib and anifrolumab added to PBS The treatments for breast cancer and lupus have now been added to the scheme, alongside medicines for leukaemia and insomnia.
Bowel cancer screening changes launch Patients aged 45 and above are now able to receive a free kit in a bid to boost plummeting screening rates and increase early diagnoses.
Australia’s ‘significant’ cancer disparities laid bare Parts of the country are recording diagnosis rates double the national average, while survival chances vary widely based on where patients live.
Bowel cancer screening rates ‘going in the wrong direction’ Despite being the nation’s second deadliest cancer, and early detection proving 99% successful for treatment, testing rates continue to fall.
In Practice: Calls for business viability representatives The RACGP is seeking members to help inform the development of its general practice business and financial viability work.
Renewed push for alcohol warning labels Research suggesting fewer than one in two Australians know drinking can cause cancer has led to a call for more public awareness.
Breast cancer detection delayed by COVID-19 The rate of metastatic breast cancer doubled after breast screening programs shut down during the pandemic.
Shared care key for cancer survivors: RACGP A new college cancer survivorship position statement highlights the role of GPs in providing holistic and comprehensive care coordination.
Age lowered for bowel cancer screening From the age of 45, eligible Australians will soon be able to screen with the national program as part of this year’s Federal Budget package.
Lack of safety data prompts guidance on oestrogen therapy A summary of evidence is out for prescribing oestrogen treatments for the estimated 75% of breast cancer patients who develop genitourinary symptoms.